We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Azura Ophthalmics announced positive topline results ...
—AZR-MD-001 is a Potential First-in-Class Therapy Targeting Meibomian Gland Dysfunction (MGD), the Root Cause of Dry Eye Disease (DED) and Contact Lens Discomfort (CLD)— TEL AVIV, Israel--(BUSINESS ...
A trio of studies from the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting show the potential of several emerging treatments for dry eye disease.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. AZR-MD-001 0.5% for the treatment of meibomian gland ...
PITTSBURGH--(BUSINESS WIRE)--American Zinc Recycling LLC (“AZR”), a leading provider of environmental services to the U.S. steel industry, today announced that Luxembourg-based Befesa S.A. (“Befesa”) ...
—AZR-MD-001 is a Potential First-in-Class Therapy Targeting Meibomian Gland Dysfunction (MGD), the Root Cause of Dry Eye Disease (DED) and Contact Lens Discomfort (CLD)— "We are very encouraged by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results